Publication | Closed Access

The multidrug-resistance protein 4 polymorphism is a new factor accounting for thiopurine sensitivity in Japanese patients with inflammatory bowel disease

InflammationMultidrug-resistance Protein 4Autoimmune DiseaseGenetic EpidemiologyImmunologyGastroenterologyPathologyThiopurine SensitivityHuman PolymorphismInflammatory MarkerUlcerative ColitisMedicineImmune-related Gene PolymorphismDrug Resistance